Search

everythinglearnresearchcommunity

for

Search:↓

Yuperio combined with bisoprolol improves heart function in patients with dilated cardiomyopathy.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Ginkgo biloba polysaccharides may reduce inflammation and promote hair growth in mice with hair loss.

Vitamin D receptor binds similarly to natural and synthetic ligands, affecting gene regulation.

Researchers found several compounds that could potentially treat Zika virus.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Vogt-Koyanagi-Harada disease affects vision and skin, mainly in people with darker skin, and is treated with steroids and immunosuppressants.

Upadacitinib may effectively treat resistant lichen planopilaris.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Young patients with Vogt-Koyanagi-Harada syndrome may have poor vision outcomes despite treatment due to frequent recurrences.

A new therapy for a skin blistering condition has not been developed yet.

The assay quickly identifies substances that increase or decrease blood vessel growth.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

The study suggests a link between varicella-zoster virus and segmental vitiligo, with evidence of the virus disrupting skin pigment cells.

Glycyrrhetinic acid from licorice may help treat acne by reducing inflammation and oil production.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Valproic acid microemulsions improve skin delivery compared to regular solutions.

Urtica dioica L. extract may help treat skin fungus but is less effective than standard treatment.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

New treatments targeting fibrosis could improve urinary symptoms in BPH.